Targeting PRMT3 Impairs Methylation and Oligomerization of HSP60 to Boost Anti-Tumor Immunity by Activating cGAS/STING Signaling
Y. Shi, Z. Wu, S. Liu, D. Zuo, Y. Niu, Y. Qiu, L. Qiao, W. He, J. Qiu, Y. Yuan, G. Wang, B. Li
This study identifies PRMT3 as a driver of immunotherapy resistance in HCC, showing that targeting it enhances anti-tumor immunity via cGAS/STING activation.
bioRxiv · May 23, 2024Cancer Biology